Sartorius Stedim, FR0013154002

Sartorius Stedim stock pre-market at EUR 214.50

Published on 10/07/2026 at 07:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius Stedim stock was at EUR 214.50 pre-market at 7:42 a.m. CEST on October 7, 2026, according to Lang & Schwarz. Recent company announcements highlighted Tunisia investments and an audit tender.

Isometrische Prozessdarstellung einer Bioprozess-Wertschöpfungskette von Zellkultur bis Abfüllung
Sartorius Stedim Biotech isometrisches 3D-Diagramm der Bioprozess-Wertschöpfungskette von Zellkultur bis Abfüllung, ISIN FR0013154002, Illustration mit AI erstellt.

Sartorius Stedim stock was at EUR 214.50 pre-market at 7:42 a.m. CEST on October 7, 2026, according to Lang & Schwarz.

Pre-market trading

The Lang & Schwarz price was recorded before the Xetra session began. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sartorius Stedim stock.

Investment in Tunisia

In a September 30, 2026, release, Sartorius Stedim Biotech said its M'Hamdia site in Tunisia had marked 25 years of biopharmaceutical manufacturing. The company said it invested more than EUR 21 million in the site's modernization and expansion between 2021 and 2025. The facility has more than 800 employees, three cleanrooms and 36 assembly lines, according to the release.

Audit tender

Sartorius Stedim Biotech also announced in a September 29, 2026 announcement that it was tendering the mandate for its annual and consolidated financial statements for fiscal 2027. The tender also covers audits of selected subsidiaries and a review of the half-year financial statements.

Disclaimer...

en | FR0013154002 | SARTORIUS STEDIM | boerse | 70251255 | bgmi